Search

everythinglearnresearchcommunity

for

Search:↓

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Japanese women typically start experiencing hair loss after 40, with reduced hair density and thickness being the main factors.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.